Effectiveness and safety of oral Chinese patent medicines as adjuvant treatment for unstable angina pectoris on the national essential drugs list of China: a protocol for a systematic review and network meta-analysis

INTRODUCTION: Achieving efficacious and safe treatments for unstable angina pectoris (UAP) is still a challenging clinical problem. The availability of different oral Chinese patent medicines frequently poses a practical challenge to clinicians, namely, which one to choose as first-line regimen for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Zhen, Zhai, Feng-Ting, Tian, Jinhui, Gao, Cheng-Fei, Xu, Peng, Zhang, Fan, Liu, Si-jia, Dong, Kun, Du, Xiao-Feng, Zhang, Zhe, Yang, Guanlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Complementary Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756357/
https://www.ncbi.nlm.nih.gov/pubmed/31542734
http://dx.doi.org/10.1136/bmjopen-2018-026136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756357/
https://www.ncbi.nlm.nih.gov/pubmed/31542734
http://dx.doi.org/10.1136/bmjopen-2018-026136

Ejemplares similares